Uric Acid and the Etiology of Diabetes, Obesity and Chronic Kidney Disease: Where Are We Now?doi:10.1016/j.freeradbiomed.2022.10.290Richard JohnsonUniversity of Colorado Denver Health Sciences, USAElsevier Inc.Free Radical Biology and Medicine...
aThe high quality semiconductor structure can be formed by epitaxially forming the semiconductor material on the seed material of island-like structure. 高质量半导体结构在海岛象结构种子材料可以由外延形成半导体材料形成。[translate] awooden 木[translate] ...
Uric Acid: Where Are We?doi:10.1111/jch.12034No abstract is available for this article.Clive Rosendorff MDFrom the Department of Medicine (Cardiology)PhDFrom the Department of Medicine (Cardiology)DScMedFrom the Department of Medicine (Cardiology)Mather R.D. Jogendra MB...
This new role of uric acid has been intensively investigated, but 3 main questions remain. Is the serum uric acid concentration a passive biomarker for cardiovascular disease, or is there a clear causal relationship? If there is, what is the mechanism? Does lowering the uric acid level reduce...
Uric Acid: Where Are We?CHRONIC HEART-FAILUREXANTHINE-OXIDASE INHIBITIONENDOTHELIALDYSFUNCTIONBLOOD-PRESSURERENAL-DISEASERISK-FACTORALLOPURINOLMORTALITYHYPERURICEMIANo abstract is available for this article.doi:10.1111/jch.12034Rosendorff, CliveJogendra, Mather R.D....
SOLUTION: This lowering agent for the uric acid value comprises a tea polyphenol derived from tea as an active ingredient and the food and drink has the lowering effects on the uric acid value. The uric acid value in a state of hyperuricemia can effectively be lowered and returned to a ...
Serum uric acid and cardiovascular disease: recent develop- ments, and where do they leave us? Am J Med 2005;118: 816-26.Baker JF, Krishnan E, Chen L, et al. Serum uric acid and cardiovascular disease: recent developments, and where do they leave us? Am J Med. 2005;118:816-826....
Uric acidCardiovascular diseaseRisk factorThe relationship between serum uric acid (SUA) and cardiovascular disease has been controversial. Here we review recent literature assessing whether hyperuricemia is an independent risk factor for adverse cardiovascular outcomes. Studies from the past 6 years ...
with the dppn ligand displaying a slight twist. When the dppn ligand is coordinated to iridium(III), the dppn ligand on the resulting complex displays a significant degree of bending along the longitudinal direction of the ligand. This iridium (III) complex crystallizes as a CH2Cl2and Et2O so...